Clinical Effectiveness and Resource Utilization of Surgery versus Endovascular Therapy for Chronic Limb-Threatening Ischemia.

Abstract

BACKGROUND:

The clinical effectiveness of surgical versus endovascular therapy for chronic limb-threatening ischemia (CLTI) continues to be debated, and the resources required for each therapy are unclear.

METHODS:

Systematic review of randomized controlled trials (RCTs) and observational studies comparing surgery with endovascular therapy for CLTI, which reported clinical effectiveness and resource utilization. Short-term and long-term clinical outcomes were examined.

RESULTS:

The search yielded 4,231 titles, of which 17 publications met our inclusion criteria. Five publications were all from 1 RCT, and 12 publications were observational studies. In the RCT, the surgical approach had greater resource use in the first year (total hospital days across all admissions for surgery versus angioplasty: 46.14 ± 53.87 vs. 36.35 ± 51.39; P < 0.001; also true for days in high-dependency and intensive therapy units), but differences were not statistically significant in subsequent years. All-cause mortality presented a nonsignificant difference favoring angioplasty in the first 2 years (adjusted hazard ratio [aHR], 1.27; 95% confidence interval [95% CI], 0.75-2.15), but after 2 years, it favored surgical treatment (aHR, 0.34; 95% CI, 0.17-0.71). The observational studies reported short-term effectiveness and resource utilization favoring endovascular therapy, but most differences were not statistically significant. Long-term outcomes were more mixed; in particular, mortality outcomes generally favored surgery, although concluding that cause and effect is not possible as endovascularly treated patients tended to be older and may have had a shorter life expectancy regardless of therapy.

CONCLUSIONS:

The clinical effectiveness and resource utilization of surgery compared with endovascular therapy for CLTI is not known with certainty and will not be known until ongoing trials report results. It is likely that findings will vary by the time horizon, where initial outcomes and utilization tend to favor endovascular interventions, but long-term outcomes favor surgical revascularization.

• Authors: Margherita Lamaina, Christopher P Childers, Charles Liu, Selene S Mak, Marika S Booth, Michael S Conte, Melinda Maggard-Gibbons, Paul G Shekelle
• Journal: Annals of vascular surgery (Ann Vasc Surg) Vol. 68 Pg. 510-521 (Oct 2020) ISSN: 1615-5947 [Electronic] Netherlands
• PMID: 32439522 (Publication Type: Journal Article, Systematic Review)
• Copyright: Published by Elsevier Inc.

Topics

• Aged
• Angioplasty (adverse effects, mortality)
• Chronic Disease
• Female
• Health Resources
• Humans
• Ischemia (diagnostic imaging, mortality, physiopathology, therapy)
• Length of Stay
• Male
• Peripheral Arterial Disease (diagnostic imaging, mortality, physiopathology, therapy)
• Randomized Controlled Trials as Topic
• Risk Factors
• Time Factors
• Treatment Outcome
• Vascular Surgical Procedures (adverse effects, mortality)